|
|
|
ix | |
| Introduction |
|
xvii | |
|
|
|
Establishing and Maintaining an IVF Laboratory |
|
|
|
Setting up an ART laboratory |
|
|
1 | (8) |
|
|
|
|
|
|
|
Quality control: maintaining stability in the laboratory |
|
|
9 | (16) |
|
|
|
The ART laboratory in the era of ISO 1000 and GLP |
|
|
25 | (14) |
|
|
|
|
|
Gamete Collection, Preparation and Selection |
|
|
|
|
|
39 | (14) |
|
|
|
|
|
Sperm preparation techniques |
|
|
53 | (14) |
|
|
|
|
|
|
|
|
|
Sperm chromatin assessment |
|
|
67 | (18) |
|
|
|
|
|
|
|
Oocyte retrieval and selection |
|
|
85 | (18) |
|
|
|
|
|
Preparation and evaluation of oocytes for ICSI |
|
|
103 | (8) |
|
|
|
|
|
Oocyte in vitro maturation |
|
|
111 | (44) |
|
|
|
|
|
|
|
|
|
|
|
Use of in vitro maturation in a clinical setting |
|
|
155 | (8) |
|
|
|
|
|
|
Equipment and general technical aspects of micromanipulation of gametes and embryos |
|
|
163 | (8) |
|
|
|
Intracytoplasmic sperm injection: technical aspects |
|
|
171 | (10) |
|
|
|
|
|
|
|
|
|
|
|
|
|
181 | (10) |
|
|
|
|
|
|
|
Human embryo biopsy procedures |
|
|
191 | (16) |
|
|
|
|
|
Culture, Selection and Transfer of the Human Embryo |
|
|
|
Analysis of fertilization |
|
|
207 | (12) |
|
|
|
Culture systems for the human embryo |
|
|
219 | (22) |
|
|
|
|
|
Evaluation of embryo quality: new strategies to facilitate single embryo transfer |
|
|
241 | (14) |
|
|
|
|
|
|
|
|
The human oocyte: controlled rate cooling |
|
|
255 | (12) |
|
|
|
|
|
The human oocyte: vitrification |
|
|
267 | (8) |
|
|
|
The human embryo: slow freezing |
|
|
275 | (14) |
|
|
|
|
|
|
|
|
|
|
|
The human embryo: vitrification |
|
|
289 | (16) |
|
|
|
|
|
|
|
|
|
Managing the cryopreserved embryo bank |
|
|
305 | (6) |
|
|
|
Cryopreservation and storage of spermatozoa |
|
|
311 | (12) |
|
|
|
|
|
Handling and Cryopreservation of testicular sperm |
|
|
323 | (4) |
|
|
|
|
|
|
|
Ovarian tissue cryopreservation and other fertility preservation strategies |
|
|
327 | (16) |
|
|
|
|
|
|
|
|
|
Diagnosis of Genetic Disease in Preimplantation Embryos |
|
|
|
Severe male factor: genetic consequences and recommendations for genetic testing |
|
|
343 | (14) |
|
|
|
|
|
|
|
|
|
357 | (14) |
|
|
|
|
|
|
|
Clinical application of polar body biopsy |
|
|
371 | (10) |
|
|
|
|
|
Preimplantation genetic diagnosis for infertility |
|
|
381 | (22) |
|
|
|
Genetic analysis of the embryo |
|
|
403 | (14) |
|
|
|
|
|
|
|
|
|
Proteomic analysis of the embryo |
|
|
417 | (10) |
|
|
|
|
|
|
Embryonic and maternal dialogue and the analysis of uterine receptivity |
|
|
427 | (8) |
|
|
|
|
|
|
|
Quality Management Systems |
|
|
|
Quality management in reproductive medicine |
|
|
435 | (12) |
|
|
|
|
|
|
|
|
|
|
|
Patient Investigation and the Use of Drugs |
|
|
|
Indications for IVF treatment: from diagnosis to prognosis |
|
|
447 | (12) |
|
|
|
|
|
|
|
Initial investigation of the patient (female and male) |
|
|
459 | (10) |
|
|
|
|
|
|
|
Drugs used for controlled ovarian stimulation: clomiphene citrate, aromatase inhibitors, metformin, gonadotropins, gonadotropin-releasing hormone analogs, and recombinant gonadotropins |
|
|
469 | (20) |
|
|
|
|
|
The role of FSH and LH in ovulation induction: current concepts |
|
|
489 | (22) |
|
|
|
|
|
|
Endocrine characteristics of ART cycles |
|
|
511 | (18) |
|
|
|
|
|
|
|
529 | (10) |
|
|
|
|
|
|
|
539 | (14) |
|
|
|
|
|
553 | (6) |
|
|
|
|
|
|
|
559 | (6) |
|
|
|
The luteal phase: luteal support protocols |
|
|
565 | (12) |
|
|
|
Treatment strategies in assisted reproduction for the low responder patient |
|
|
577 | (40) |
|
|
|
|
|
Repeated implantation failure: the preferred therapeutic approach |
|
|
617 | (18) |
|
|
|
|
|
Technical Procedures and Outcomes |
|
|
|
|
|
635 | (22) |
|
|
|
Sperm-recovery techniques: clinical aspects |
|
|
657 | (16) |
|
|
|
|
|
Gamete intrafallopian transfer (GIFT) and zygote intrafallopian transfer (ZIFT) |
|
|
673 | (20) |
|
|
|
|
|
|
|
693 | (8) |
|
|
|
|
|
Anesthesia and in-vitro fertilization |
|
|
701 | (6) |
|
|
|
Medical considerations of single embryo transfer |
|
|
707 | (4) |
|
|
|
Special Medical Conditions |
|
|
|
|
|
711 | (10) |
|
|
|
|
|
|
|
Polycystic ovaries and ART |
|
|
721 | (16) |
|
|
|
|
|
Prognostic testing for ovarian reserve |
|
|
737 | |
|
|
|
|
|
|
|
Management of hydrosalpinx |
|
|
547 | (212) |
|
|
|
Complications of Treatment |
|
|
|
Severe ovarian hyperstimulation syndrome |
|
|
759 | (14) |
|
|
|
|
|
The environment and reproduction |
|
|
773 | (14) |
|
|
|
|
|
Bleeding, severe pelvic infection, and ectopic pregnancy |
|
|
787 | (8) |
|
|
|
|
|
Iatrogenic multiple pregnancy: the risk of ART |
|
|
795 | (12) |
|
|
|
Egg Donation and Surrogate Motherhood |
|
|
|
|
|
807 | (10) |
|
|
|
|
|
|
|
817 | (10) |
|
|
|
Future Directions and Clinical Applications |
|
|
|
Human embryonic stem cells |
|
|
827 | (16) |
|
|
|
|
|
Microfluidics in ART: current progress and future directions |
|
|
843 | (16) |
|
|
|
|
|
|
|
|
|
|
|
|
The evolving role of the ART nurse: a contemporary review |
|
|
859 | (8) |
|
|
|
Patient support in the ART program |
|
|
867 | (10) |
|
|
|
The relationship between stress and in vitro fertilization outcome |
|
|
877 | (8) |
|
Andrea Mechanick Braverman |
|
|
|
|
|
The impact of legislation and socioeconomic factors in the access to and global practice of ART |
|
|
885 | (10) |
|
Fernando Zegers-Hochschild |
|
|
|
|
Recent ethical dilemmas in ART |
|
|
895 | (8) |
|
|
| Index |
|
903 | |
